Literature DB >> 7770767

IL-12 at the crossroads.

S S Hall.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7770767     DOI： 10.1126/science.7770767

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  10 in total

Review 1.  Probiotics and immune response.

Authors:  Stephanie Blum; Dirk Haller; Andrea Pfeifer; Eduardo J Schiffrin
Journal:  Clin Rev Allergy Immunol       Date:  2002-06       Impact factor: 8.667

2.  Activation of human peripheral blood mononuclear cells by nonpathogenic bacteria in vitro: evidence of NK cells as primary targets.

Authors:  D Haller; S Blum; C Bode; W P Hammes; E J Schiffrin
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Patent filarial infection modulates malaria-specific type 1 cytokine responses in an IL-10-dependent manner in a filaria/malaria-coinfected population.

Authors:  Simon Metenou; Benoit Dembélé; Siaka Konate; Housseini Dolo; Siaka Y Coulibaly; Yaya I Coulibaly; Abdallah A Diallo; Lamine Soumaoro; Michel E Coulibaly; Dramane Sanogo; Salif S Doumbia; Marissa Wagner; Sekou F Traoré; Amy Klion; Siddhartha Mahanty; Thomas B Nutman
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

4.  Cytokine expression in B-CLL in relation to disease progression and in vitro activation.

Authors:  M Aguilar-Santelises; D Gigliotti; L M Osorio; A D Santiago; H Mellstedt; M Jondal
Journal:  Med Oncol       Date:  1999-12       Impact factor: 3.064

5.  Cytokine induction by Streptococcus mutans and pulpal pathogenesis.

Authors:  C L Hahn; A M Best; J G Tew
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

6.  Interleukin-12 is critical for induction of nitric oxide-mediated immunosuppression following vaccination of mice with attenuated Salmonella typhimurium.

Authors:  M G Schwacha; T K Eisenstein
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

7.  Potentiality of interleukin-18 as a useful reagent for treatment and prevention of Leishmania major infection.

Authors:  K Ohkusu; T Yoshimoto; K Takeda; T Ogura; S Kashiwamura; Y Iwakura; S Akira; H Okamura; K Nakanishi
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

8.  Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice.

Authors:  Shivali Gupta; Nisha Jain Garg
Journal:  PLoS Negl Trop Dis       Date:  2010-08-10

9.  Differential production of interleukin-12 mRNA by murine macrophages in response to viable or killed Salmonella spp.

Authors:  C Chong; K L Bost; J D Clements
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

10.  Therapeutic effect of interleukin 12 on mouse haemangiosarcomas is not associated with an increased anti-tumour cytotoxic T-lymphocyte activity.

Authors:  C Vizler; A Rosato; F Calderazzo; L Quintieri; P Fruscella; R Wainstok de Calmanovici; A Mantovani; A Vecchi; P Zanovello; D Collavo
Journal:  Br J Cancer       Date:  1998-02       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.